Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Our Products
MouseAtlas
iPSC Cell Lines
Knockout Cell Lines
Tumor Cell Lines
Adeno-associated Virus (AAV) Standard Capsid
Featured Catalog
Humanized Mouse Models
HUGO-GT™
HUGO-Ab™
Humanized Target Gene Models
Humanized Immune System Mouse Models
Tool Mice
Cre Mouse Lines
Disease Models
Autoimmune Disease Models
Ophthalmic Disease Models
Immunodeficient Mouse Models
Metabolic Disease Models
Neurological Disease Models
Oncology & Immuno-oncology Models
Services
Model Generation Techniques
Turboknockoutᵀᴹ Gene Targeting
Cre-ESCs Gene Editing
Targeted Gene Editing
Genetically Engineered Animals
Knockin Mice
Knockin Rats
Knockout Mice
Knockout Rats
Transgenic Mice
Transgenic Rats
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Adenovirus Packaging
Lentivirus Packaging
Custom Cell Line Services
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Overexpression Cell Lines
Point Mutation Cell Lines
Breeding & Supporting Services
BAC Modification
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
Drug Discovery and Development
Antibody Discovery Platform
HUGO-Mab™
HUGO-Light™
HUGO-Ab-eKO™
Therapeutic Area
Neurology
Alzheimer's Disease (AD)
Parkinson's Disease (PD)
Huntington's Disease (HD)
Blood Brain Barrier (BBB)
Metabolic & Cardiovascular
Obesity
Ophthalmology
Glaucoma
Age-Related Macular Degeneration (AMD)
Oncology
PBMC Humanized Mouse Model
Human Immune System (HIS) Mouse Model
Immunology & Inflammation
Asthma
Innovative Drug R&D
Therapeutic Antibody Drugs
Monoclonal Antibodies (mAb)
ADC/AOC
AI-Powered AAV Discovery
Cell Immunotherapy
Gene Therapy
Oligonucleotide Therapy
Resources
News
Blogs & Insight
Promotion
Events & Webinars
Databases
AbSeek
Rare Disease Data Center
Cell iGeneEditor™ System
Peer-Reviewed Citations
Resource Vault
OriCell
About Us
Animal Health & Welfare
Corporate Overview
Facility Overview
Our Team
Our Partners
Careers
Health Reports
Contact Us
Login
HomeMouseAtlas
C57BL/6JCya-Prozem1/Cya
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
+
-
Organization
Job Role
Country
Catalog Type
Product Name
Main Area of Research
How did you hear about us?
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.

C57BL/6JCya-Prozem1/Cya

Common Name
Proz-KO
Product ID
S-KO-18777
Backgroud
C57BL/6JCya
Strain ID
KOCMP-66901-Proz-B6J-VB
Status
Research and Development
When using this mouse strain in a publication, please cite “Proz-KO Mouse (Catalog S-KO-18777) were purchased from Cyagen.”
KO Models
Product Type
Age
Genotype
Sex
Quantity
The standard delivery applies for a guaranteed minimum of three heterozygous carriers. Breeding services for homozygous carriers and/or specified sex are available.
+
KO Models
Basic Information
Strain Name
Proz-KO
Strain ID
KOCMP-66901-Proz-B6J-VB
Gene Name
Proz
Product ID
S-KO-18777
Gene Alias
1300015B06Rik
Background
C57BL/6JCya
NCBI ID
66901 (Mouse)
Modification
Conventional knockout
Chromosome
Chr 8 (Mouse)
Phenotype
MGI:1860488
Datasheet
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Strain Description
Ensembl Transcript ID
ENSMUST00000033822
NCBI Transcript ID
NM_025834
Target Region
Exon 2
Size of Effective Region
~1.0 kb
Overview of Gene Research
PROZ, also known as the gene encoding vitamin K-dependent protein Z, is a gene with significant biological importance. Protein Z is a vitamin K-dependent plasma protein that is canonically considered to have anticoagulant effects through negative regulation of factor Xa [3,4]. It may also be involved in other biological processes as it has been associated with various diseases, indicating its role in different physiological pathways. Genetic models can be valuable for further exploring its functions.

In hepatocellular carcinoma, low PROZ expression is significantly correlated with poor prognosis. PROZ is closely related to the expression of p-ERK and VEGFR2, and its down-regulation in sorafenib-resistant strains is accompanied by increased p-ERK and decreased VEGFR2. Also, PROZ is negatively correlated with genes related to immunotherapy efficacy and T-cell infiltration in tumor tissue, suggesting it may serve as a potential target to improve the efficacy of targeted combined immunotherapy [1]. In early hepatocellular carcinoma, PROZ expression is decreased compared to normal liver controls, and low PROZ expression might result in poor overall survival [2].

Loss-of-function in PROZ is associated with an increased risk of non-cardioembolic ischemic stroke in the UK Biobank, consistent with its role as an anticoagulant factor [3]. In a multi-ethnic study of young and middle-aged adults, there was evidence of a non-linear positive association between PZ level (encoded by PROZ) and unexplained stroke, with genetic variants related to PZ levels also showing an association with cryptogenic stroke [4].

PROZ levels are decreased in patients with prediabetes and type 2 diabetes, and there are negative correlations between PROZ and fasting plasma glucose and hemoglobin A1c, suggesting it may be a biomarker for early detection of prediabetes [5].

In preterm birth, increased PROZ expression in amniotic fluid is associated with the occurrence of PTB, and PROZ promotes the proliferation and migration of amniotic membrane fibroblasts [6]. Polymorphisms of PROZ gene are associated with recurrent spontaneous abortion in Chinese Han women [7].

In conclusion, PROZ, encoding protein Z, has a crucial role in multiple biological processes, especially in coagulation. Its dysregulation is associated with various diseases such as hepatocellular carcinoma, ischemic stroke, diabetes, preterm birth, and recurrent spontaneous abortion. Studies, especially those related to loss-of-function, have provided insights into its role in these disease conditions, which may help in developing new diagnostic and therapeutic strategies.

References:
1. Chen, Yinkui, Qiu, Xiusheng, Wu, Donghao, Xiong, Zhiyong, Wang, Tiantian. 2022. PROZ Associated with Sorafenib Sensitivity May Serve as a Potential Target to Enhance the Efficacy of Combined Immunotherapy for Hepatocellular Carcinoma. In Genes, 13, . doi:10.3390/genes13091535. https://pubmed.ncbi.nlm.nih.gov/36140703/
2. Jiang, Xiaocong, Song, Ting, Pan, Xiuhua, Lan, Yuhong, Bai, Li. 2021. PROZ May Serve as a Prognostic Biomarker for Early Hepatocellular Carcinoma. In International journal of general medicine, 14, 4209-4218. doi:10.2147/IJGM.S311959. https://pubmed.ncbi.nlm.nih.gov/34393500/
3. Haj, Amelia K, Ryu, Justine, Jurgens, Sean J, Ellinor, Patrick T, Bendapudi, Pavan K. 2024. Loss of function in protein Z (PROZ) is associated with increased risk of ischemic stroke in the UK Biobank. In Journal of thrombosis and haemostasis : JTH, 23, 171-180. doi:10.1016/j.jtha.2024.09.016. https://pubmed.ncbi.nlm.nih.gov/39383998/
4. Zhang, Lili, Segal, Alan Z, Leifer, Dana, Devereux, Richard B, Kizer, Jorge R. 2016. Circulating protein Z concentration, PROZ variants, and unexplained cerebral infarction in young and middle-aged adults. In Thrombosis and haemostasis, 117, 149-157. doi:10.1160/TH16-04-0277. https://pubmed.ncbi.nlm.nih.gov/27683756/
5. Bae, Yun-Ui, You, Ji Hong, Cho, Nan Hee, Park, Jae-Hyung, Cho, Ho Chan. 2021. Association of Protein Z with Prediabetes and Type 2 Diabetes. In Endocrinology and metabolism (Seoul, Korea), 36, 637-646. doi:10.3803/EnM.2021.962. https://pubmed.ncbi.nlm.nih.gov/34074095/
6. Chen, Siguo, Wang, Weizhou, Yan, Guanghong, Zhou, Linglin, You, Dingyun. 2024. Amniotic Fluid Proteomics Analysis and In Vitro Validation to Identify Potential Biomarkers of Preterm Birth. In Reproductive sciences (Thousand Oaks, Calif.), 31, 2032-2042. doi:10.1007/s43032-024-01457-3. https://pubmed.ncbi.nlm.nih.gov/38453771/
7. Xu, Zuying, Zhang, Ying, Liu, Wei, Cao, Yunxia, Xiang, Huifen. 2018. Polymorphisms of F2, PROC, PROZ, and F13A1 Genes are Associated With Recurrent Spontaneous Abortion in Chinese Han Women. In Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 24, 894-900. doi:10.1177/1076029617750487. https://pubmed.ncbi.nlm.nih.gov/29363996/
Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Contact Us
Connect with our experts for your custom animal model needs. Please fill out the form below to start a conversation or request a quote.
Inquiry Details
Main Area of Research
Service(s) of Interest
Gene of Interest
Project Details
How did you hear about us?
Contact Information
Full Name
Email
Phone Number
+
-
Organization
Job Role
Country
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our  Privacy Policy  for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0336
Email:
inquiry@cyagen.com
Services
HUGO-GT™HUGO-Ab™iPSC Cell LinesAdeno-associated Virus (AAV) Standard Capsid
Drug R&D
NeurologyMetabolicOphthalmologyOncology
About Us
Animal Health & WelfareCorporate OverviewOur TeamHealth Reports
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Global Antibody Drug Industry Development BlueBook (Frost & Sullivan)
Key Insights
The industry is undergoing a rapid transformation driven by next-generation modalities, globalized markets, and upstream technological innovations.
  • Market Structural Shift: Monoclonal antibodies drive steady growth, but ADCs and bispecifics are rapidly accelerating, reshaping the market with higher-value innovations.
  • Chinese Market Globalization: China is actively expanding globally, evidenced by a surge in high-value cross-border license-out deals.
  • Technology-Driven Efficiency: Advanced discovery engines—exemplified by Cyagen's HUGO-Ab platform and AI algorithms—are streamlining candidate screening, optimizing molecular design, and localizing the upstream supply chain.
  • Oncology-Focused Innovation: R&D pipelines remain heavily concentrated on high-incidence malignancies like non-small cell lung cancer, utilizing complex modalities to combat clinical resistance.
Now Available for Download
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest
Main Area of Research